vitronectin antagonists (Merck)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namevitronectin antagonists (Merck)
Drug Alias Namealpha-v/beta-3 antagonists (Merck & Co)L-806977
ClassificationSmall molecules
Mechanisms of ActionIntegrin alpha-V/beta-3 antagonistsBone modulators
TargetsIntegrin alpha-V/beta-3
Therapy Area/IndicationsOsteoporosisBone Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck & Co Inc
Active IndicationsN/A
Inactive IndicationsOsteoporosisBone Diseases

Other Information

ATC CodeN/A
Related LinksN/A